Treats inflammatory papules and pustules of rosacea. ANDA 77547, held by Encube Ethicals. Metronidazole.
As of Nov 21, 2026, ANDA 77547 (Metronidazole), held by Encube Ethicals, was first approved by FDA on Jul 13, 2006, with 1 approved supplement and 0 published complete response letters.
INDICATIONS AND USAGE Metronidazole gel USP (topical), 0.75%, is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 13, 2006 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metronidazole0.75% · gel;topical | Metronidazole | Rx |
| Jun 14, 2015 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jul 13, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters